Short answer
Alkermes plc. (ALKS) filed an 8-K current report with the SEC on November 3, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1), Item EX-99.2 (Exhibit EX-99.2). Q3 and nine-month financial results announced for periods ended September 30, 2026.
Alkermes plc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q3 and nine-month financial results announced for periods ended September 30, 2026
- Investor presentation accompanies results, supporting management’s November 3, 2026 conference call
- Investors should review Exhibits 99.1 and 99.2 for financial metrics and outlook details
Item EX-99.1 · Exhibit EX-99.1
- Q3 revenue $480.1M, up from $394.2M, driven by $89.9M LUMRYZ sales and stronger proprietary products
- LUMRYZ reached approximately 4,100 patients, establishing meaningful commercial traction following the Avadel acquisition
- GAAP net income fell to $16.3M from $82.8M, reflecting $27.6M interest expense and $29.8M Avadel acquisition costs
- Adjusted EBITDA $120.1M versus $121.5M, showing stable underlying profitability despite higher R&D and commercial investment
- Cash and investments $787.6M, while debt reached $1.50B, materially increasing leverage and financing risk after Avadel acquisition
Item EX-99.2 · Exhibit EX-99.2
- Q3 revenue $480.1M, up from $394.2M, driven by Avadel acquisition and LUMRYZ sales of $89.9M
- Proprietary net sales rose to $417.3M from $317.4M, while manufacturing and royalty revenue declined to $62.9M
- Q3 GAAP net income fell to $16.3M from $82.8M, with interest expense and Avadel-related costs weighing on profitability
- FY2026 revenue outlook maintained at $1.73B-$1.84B, including LUMRYZ sales of $315M-$335M
- FY2026 adjusted EBITDA outlook maintained at $370M-$410M despite projected GAAP net loss of $95M-$115M
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Alkermes plc. 8-K filings
Get the next ALKS 8-K as it lands
Follow ALKS for push alerts, or ask the research agent what this filing means.